How does anticoagulant therapy improve outcomes in patients with thrombotic thrombocytopenic purpura (TTP), and what challenges exist in treatment?
Gaurav ChauhanContributor
How does anticoagulant therapy affect outcomes in patients with thrombotic thrombocytopenic purpura (TTP)?
Share
Anticoagulant therapy is generally not the primary treatment for TTP, as the mainstay is plasma exchange. Anticoagulants may be used adjunctively to prevent clot complications but may increase bleeding risk.